Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
International Journal of Clinical Pharmacology and Therapeutics|July 26, 2011
A systematic review of available clinical evidence - filgrastim compared with lenograstimH Sourgens, F LefrèreGynecologie, Obstetrique & Fertilite|October 6, 2007
[Increased risk of relapse in multiple sclerosis patients after ovarian stimulation for in vitro fertilization]D-A Laplaud, F Lefrère, E Leray, et al.Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 7, 2014
[Cost per responder associated with romiplostim and rituximab treatment for adult primary immune thrombocytopenia in France]L Chiche, A Perrin, L Stern, et al.The Journal of Infectious Diseases|April 1, 1994
Provirus copy number to predict disease progression in asymptomatic human immunodeficiency virus type 1 infectionS Chevret, M Kirstetter, M Mariotti, et al.Bone Marrow Transplantation|August 1, 1996
Transmission of Plasmodium falciparum by allogeneic bone marrow transplantationF Lefrère, C Besson, A Datry, et al.British Journal of Haematology|October 1, 1992
Towards a new predictor of AIDS progression through the quantitation of HIV-1 DNA copies by PCR in HIV-infected individualsJ J Lefrère, M Mariotti, E Wattel, et al.Hematology and Cell Therapy|August 11, 1998
The feasibility of peripheral blood stem cell collection for autograft following failure in bone marrow aspirationF Lefrère, O Hermine, F Audat, et al.Transfusion|December 22, 1999
The dose of granulocyte-colony-stimulating factor after chemopriming treatment does not influence apheresis yield of progenitor cells: a retrospective study of 91 casesF Lefrère, C Belanger, F Audat, et al.Transfusion|June 23, 1999
The timing of granulocyte-colony-stimulating factor administration after chemotherapy does not affect stem and progenitor cell apheresis yield: a retrospective study of 65 casesF Lefrère, F Audat, O Hermine, et al.Pageof 3